Human Normal Immunoglobulin & Anti-D Immunoglobulin
key details
| Value | £450,000,000 |
|---|---|
| Status | planned |
| Category (CPV) | 33651520 |
| Region | Scotland, Wales, Northern Ireland |
| Contract start | 1 Jul 2021 |
| Contract end | 31 Dec 2022 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-1fe67c5e-61dc-49b0-8106-efcb90223924 |
description
Human Normal Immunoglobulin and Anti-D Immunoglobulin:
Period of framework agreement: 1 July 2021 to 31 December 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Jan 2021 | Planning (planning) | · | a52fee91-6ad1-4eb1-b48f-08ff6819a535-406253 |
more from NHS ENGLAND
- Products for the treatment of Haemophilia A · £215,000,000 · 11 May 2023
- NHS Framework Agreement for the supply of products for the treatment of Haemophilia A · £215,000,000 · 26 Apr 2023
- NHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin · £526,598,540 · 3 Feb 2023
- NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care · £16,000,000 · 22 Jul 2022
- National Framework Agreement for the supply of products for the management of Hereditary Angioedema · £74,500,000 · 5 Jul 2022
- NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema · £74,500,000 · 5 Jul 2022
- NHA National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B · £250,000,000 · 5 Jul 2022
- NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A · £214,000,000 · 22 Mar 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin · NHS England · £1,200,000,000
- NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin · NHS ENGLAND
- SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT) · Ministry of Defence
- SARS-CoV-2 Nucleocapsid proteins for LFT Revalidation and Testing · UK Health Security Agency · £500,000
- CMU Framework for the supply of Anti-D Immunoglobulin · University Hospitals of Leicester NHS Trust · £209,801
- PHE_Scientific Provision for purchase of the Euroimmun Anti SARS CoV 2 IgG assay · Public Health England · £158,400
- NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga) · The NHS Commissioning Board (operating under the name of NHS England)
- 1LHE Goods - Antibodies · NEWCASTLE UNIVERSITY · £25,115
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.